Myths vs facts: COMT and gut health

Claims that COMT variants directly impact gut health are not well supported by current evidence. COMT (catechol-O-methyltransferase) metabolizes catecholamines like dopamine and adrenaline. Some research suggests a role in the gut-brain axis, but the evidence is mostly mechanistic or from animal models. There are no robust human studies linking specific COMT SNPs (e.g., rs4680) to gut disorders like IBS or inflammation. Many direct-to-consumer DNA tests market such associations without highlighting small effect sizes and lack of replication. The fact is: gut health is influenced by diet, microbiome, stress, and many genes – COMT is just one small piece. Without accompanying biomarkers or clinical symptoms, gut health predictions from COMT alone are not valid. Be cautious of overblown marketing claims.